about
A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalizationAlert cell strategy in SIRS-induced vasculitis: sepsis and endothelial cellsProtein C anticoagulant and cytoprotective pathwaysTurning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug developmentCrystal Structure of Thrombin Bound to the Uncleaved Extracellular Fragment of PAR1Evolution of the protease-activated receptor family in vertebratesSerine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behaviorDiscovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376cThe Role of DNA Methylation in Cardiovascular Risk and Disease: Methodological Aspects, Study Design, and Data Analysis for Epidemiological Studies.Thrombin-inducible platelet adhesion and regulation of the platelet seven-transmembrane thrombin receptor-1 (PAR-1): effects of unfractionated heparin and lepirudin.Hemostatic abnormalities in uncomplicated babesiosis (Babesia rossi) in dogs.Thrombin induced connective tissue growth factor expression in rat vascular smooth muscle cells via the PAR-1/JNK/AP-1 pathway.Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells.PAR-2, IL-4R, TGF-β and TNF-α in bronchoalveolar lavage distinguishes extrinsic allergic alveolitis from sarcoidosisEndosomal signaling by protease-activated receptors.Tobacco-smoking-related differential DNA methylation: 27K discovery and replicationProtein targets of inflammatory serine proteases and cardiovascular disease.Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease.Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregationNeuroprotective effect of protease-activated receptor-2 in the hypoxia-induced apoptosis of rat RGC-5 cells.Regulation of thrombospondin1 by extracellular proteases.F2RL3 methylation in blood DNA is a strong predictor of mortality.TAILS N-terminomics of human platelets reveals pervasive metalloproteinase-dependent proteolytic processing in storage.Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction.Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention.Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils.F2RL3 methylation as a biomarker of current and lifetime smoking exposuresRelation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography.Activation of factor XI by products of prothrombin activationEffect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functionsDNA methylation in white blood cells: association with risk factors in epidemiologic studies.Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.We can do it together: PAR1/PAR2 heterodimer signaling in VSMCsProtease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.Competition-cooperation relationship networks characterize the competition and cooperation between proteins
P2860
Q24299867-9BE51601-42DA-4453-B13D-F831B38E35A4Q26751597-18EE7A8F-3A30-4B0F-B223-583E975D25E3Q26999113-044EC4DE-2647-43B7-8689-BE38A0764539Q27024397-2787F95C-54D0-4FF9-9EAB-60238B580D83Q27660263-82B34152-8CDF-4DE4-BF3D-D754A96AC390Q28603611-ADF68472-9E5A-490D-A572-C619546F97E8Q28741929-C619292F-38FF-46B2-8E1A-92E93F16F95FQ28829391-4D1D44D5-D2CC-4AEE-BD2C-C1ACAE89FCCEQ30558959-CBB44436-783E-48B2-8DA0-C032A420EE3CQ31042331-1DF9E851-F38B-47A3-A086-807C5AF5B256Q33387126-CC1EFE4B-76B9-40B1-B771-546455D166F8Q33404618-BD776E2C-158B-49EB-95D1-A1410B4E4391Q33566993-116512EF-DE0B-4DCB-8C47-6C76617582FBQ33765419-3397AABD-2938-43BB-B362-5AD8FE79F4CAQ33837416-EF2F5517-C094-4A3D-9750-602DC441BF74Q33856835-D6B48DC3-DC13-44A5-AA17-98F803661343Q33860650-623A7367-3462-4EDA-BE62-650899584140Q34114355-3DDDAD07-C905-4AEB-BAD9-BA5A2322815CQ34148307-C9369FB6-CD44-4677-9580-9329FAAB2A82Q34236472-0F0679ED-8683-403A-BCC8-A07FD16BADE0Q34282119-F6F8CD54-C7CF-4FB2-8CBD-7DD2111C3460Q34342288-04E41A59-B882-4A02-A58A-A1138CDF3951Q34403337-F59C05F9-4612-4C3E-A335-BC025C41CE4DQ34441372-65D0F904-BD15-413F-8F97-B5D3F6D2A209Q34649151-877905E5-C3A9-473D-8824-C66B326B2192Q34737567-FB4F3BE9-C106-414B-829B-E9B726F1FC68Q34760729-C7F1E0C2-6BEC-4973-8C6B-DDBC2752F5F0Q34906975-34BA844B-23E7-42B5-8C7F-119CC3797193Q34937666-A5A7DF12-7C51-4B5E-9BCC-900759B10F5FQ35052285-CEC71EB9-FAA5-48EC-8EBA-BAD0C0701CDFQ35091397-FAACEC70-AD4C-43A9-9304-D65570E4FDDDQ35112259-2C191D0A-473D-4790-B8BE-E42627C20CB8Q35128047-7ACB94A9-9E4B-467D-8AD9-AA20CBA97EB7Q35150513-0BDFC6D0-A309-44A0-AD10-BF74FC89CBF0Q35159029-E0A8BCCA-6B89-4B6E-BC93-63ABC24AAB1AQ35212303-52D671B4-1BEC-40C4-ACA0-A1362BE7579CQ35599925-5EEA1F8F-8DE4-47E5-9DCF-1E864AA45489Q35620514-078AA285-4D96-4527-9B1C-3BBE909E372BQ35776992-D9D33FAF-7FC7-4F01-BA4F-AA6A231A6490Q35778357-2799729C-243D-40E6-BBA1-5D388C2B6E19
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Protease-activated receptors in cardiovascular diseases
@ast
Protease-activated receptors in cardiovascular diseases
@en
Protease-activated receptors in cardiovascular diseases
@nl
type
label
Protease-activated receptors in cardiovascular diseases
@ast
Protease-activated receptors in cardiovascular diseases
@en
Protease-activated receptors in cardiovascular diseases
@nl
prefLabel
Protease-activated receptors in cardiovascular diseases
@ast
Protease-activated receptors in cardiovascular diseases
@en
Protease-activated receptors in cardiovascular diseases
@nl
P2093
P3181
P1433
P1476
Protease-activated receptors in cardiovascular diseases
@en
P2093
Andrew J Leger
Athan Kuliopulos
Lidija Covic
P304
P3181
P356
10.1161/CIRCULATIONAHA.105.574830
P407
P577
2006-09-05T00:00:00Z